A Study of People With CD30 Positive Lymphoma in China

CompletedOBSERVATIONAL
Enrollment

1,006

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

July 3, 2024

Study Completion Date

July 3, 2024

Conditions
Lymphoma
Trial Locations (11)

100010

Peking University Third Hospital, Beijing

110002

The First Affiliated Hospital of China Medical University, Shenyang

200065

Shanghai Tongji Hospital, Shanghai

210000

Jiangsu Province Hospital/the Firstaffiliated Hospital Withnanjing Medical University, Nanjing

215000

The Firstaffiliated Hospital Ofsoochow University, Suzhou

230031

Anhui Provincial Cancer Hospital, Hefei

250000

Provincial Hospital Affiliated to Shandong First Medical University (Shandong Provincial Hospital), Shandong

330006

The First Affiliated Hospital of Nanchang University, Nanchang

361003

The First Affiliated Hospital of Xiamen University, Xiamen

430022

Union Hospital AffiliatedProf to Tongji Medical College, Huazhong University of Science and Technology, Wuhan

430030

Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY